Inactive Instrument

All News Pfizer Inc Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

09:58pm	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
07:25pm	Pfizer Gets FDA Approval for Bleeding Disorder Treatment	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Edge Higher Late Afternoon	03:58pm	MT
Pfizer Gets FDA Approval for Bleeding Disorder Treatment	01:25pm	MT
Sector Update: Health Care Stocks Mixed Premarket Friday	09:43am	MT
Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment	09:09am	MT
Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment	07:47am	MT
Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment	07:44am	MT
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B	07:15am	DJ
US FDA approves Pfizer's gene therapy for rare bleeding disorder	06:46am	RE
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B	06:46am	BU
Sector Update: Health Care Stocks Drop in Afternoon Trading	Apr. 25	MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	Apr. 25	MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines	Apr. 25	MT
GSK Files Lawsuit Against Pfizer, BioNTech Over mRNA Patents Infringement	Apr. 25	MT
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology	Apr. 25	RE
Bristol Myers posts quarterly loss, revenue rises 5%	Apr. 25	RE
Scholz promises support for pharma sector in Germany as Merck invests	Apr. 25	RE
Pfizer Keeps Q2 Dividend at $0.42 a Share, Payable June 14 to Holders of Record May 10	Apr. 24	MT
Pfizer Declares Second-Quarter 2024 Dividend	Apr. 24	BU
Pfizer Inc. Declares Second-Quarter 2024 Dividend, Payable on June 14, 2024	Apr. 24	CI
Pfizer : Political Action Committee (PAC) Report	Apr. 24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT